CEO
DB
Darwin Biosciences
Darwin Biosciences develops saliva-based diagnostic tests that utilize biological signals in saliva for the early detection of infectious diseases. This technology provides a non-invasive and efficient method for identifying infections, enabling timely medical intervention.
- Biotechnology
- Healthcare Technology
Updated 7 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Features
- Darwin Biosciences develops saliva-based diagnostic tests that utilize biological signals in saliva for the early detection of infectious diseases. This technology provides a non-invasive and efficient method for identifying infections, enabling timely medical intervention.